SCHEMBL802817

SCHEMBL802817

CCOCOC(=O)COCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
L3MBTL1 Q9Y468 3/20 0.47
MAPK1 P28482 2/20 0.47
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TSHR P16473 2/20 0.45
CSNK1D P48730 1/20 0.44
NPC1 O15118 1/20 0.43
MAPT P10636 1/20 0.43
TDP1 Q9NUW8 2/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A3 Q01959 1/20 0.43
KMT2A Q03164 1/20 0.43
GRM5 P41594 1/20 0.42
PAM P19021 1/20 0.42
ABCB1 P08183 1/20 0.42
LMNA P02545 1/20 0.41
PPID Q08752 1/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL52219 0.90 ALDH1A1 (0.52) ALDH1A1L3MBTL1MAPK1TSHRCSNK1D
SCHEMBL12304981 0.86 ALDH1A1 (0.59) ALDH1A1L3MBTL1MAPK1RAB9ASMN1; SMN2
SCHEMBL419807 0.84 ALDH1A1 (0.66) ALDH1A1L3MBTL1MAPK1SMN1; SMN2TSHR
SCHEMBL27358219 0.84 TDP1 (0.49) ALDH1A1L3MBTL1MAPK1RAB9ASMN1; SMN2
SCHEMBL16672447 0.83 LMNA (0.50) ALDH1A1L3MBTL1MAPK1RAB9ASMN1; SMN2
SCHEMBL21801168 0.82 ALDH1A1 (0.47) ALDH1A1L3MBTL1MAPK1SMN1; SMN2TSHR
SCHEMBL23684580 0.81 PAM (0.65) ALDH1A1L3MBTL1MAPK1RAB9ASMN1; SMN2
SCHEMBL27338787 0.81 ALDH1A1 (0.53) ALDH1A1L3MBTL1MAPK1RAB9ASMN1; SMN2
Ether SCHEMBL954914 0.81 ALDH1A1 (0.50) ALDH1A1L3MBTL1MAPK1RAB9ASMN1; SMN2
SCHEMBL24722404 0.81 ALDH1A1 (0.46) ALDH1A1L3MBTL1MAPK1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8404222-B2 Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution NEKTAR THERAPEUTICS (US) 2013-03-26 US disclosed
US-20120071627-A1 Soluble, Degradable Poly(ethylene glycol) Derivatives for Controllable Release of Bound Molecules into Solution NEKTAR THERAPEUTICS (US) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071627-A1 Soluble, Degradable Poly(ethylene glycol) Derivatives for Controllable Release of Bound Molecules into Solution IDE, EGFR, IDUA ALDH1A1 1709/4885L3MBTL1 3666/4885MAPK1 3043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.